Cost-effectiveness of rituximab as maintenance treatment for relapsed follicular lymphoma: results of a population-based study

H.M. Blommestein, D.E. Issa, M. Pompen, G. Ten Hoor, M. Hogendoorn, P. Joosten, S. Zweegman, P.C. Huijgens, C.A. Uyl-de Groot

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)398-406
JournalEuropean Journal of Haematology
Volume92
Issue number5
DOIs
Publication statusPublished - 2014

Cite this